Primary Record
vinblastine
- In stock
- 9,939 g
- Purity
- 99.2 %
- CAS
- 865-21-4
Compound Identifiers & Properties
- CAS
- 865-21-4
- PubChem CID
- 13342
- SMILES
- CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
- Canonical SMILES
- CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
Names & Synonyms
- vinblastine
- Vinblastin
- Vincaleukoblastine
- Vinblastina
- Vincaleucoblastin
- Vincoblastine
- Vincaleucoblastine
- Vinblastinum
- Rozevin
- Nincaluicolflastine
- Vinblastine sulfate
- Velbe
- Vinrosidine
- Vinblastina [DCIT]
- Velban
- 865-21-4
- Vinblastina Lilly
- Vinblastine [INN:BAN]
- Vinblastina (TN)
- Vinblastinum [INN-Latin]
- Vinblastine sulphate
- [3H]-Vinblastine
- Vinblastine (INN)
- 2 -Epivinblastine
- 5V9KLZ54CY
- RefChem:6350
- VR-8
- 1z2b
- CHEMBL159
- UNII-5V9KLZ54CY
- VINBLASTINE [MI]
- CCRIS 9002
- VINBLASTINE [INN]
- C46H58N4O9
- NCI-C04842
- VINBLASTINE [HSDB]
- D0W9MM
- HSDB 3263
- VINBLASTINE [VANDF]
- 2 -Epivincaleukoblastine
- AC1L21JC
- SCHEMBL3628
- SCHEMBL3629
- BIDD:PXR0201
- NSC 47842
- BSPBio_001228
- VINBLASTINE [WHO-DD]
- (2 R)-Vincaleukoblastine
- EINECS 212-734-0
- JXLYSJRDGCGARV-CFWMRBGOSA-N
- NSC 49842
- NSC-47842
- DTXCID801430
- GTPL6851
- orb1685623
- 29060-LE
- DTXSID8021430
- CHEBI:27375
- cid_5388983
- L01CA01
- MFCD05662370
- NDC 0002-1452-01
- Vincristine Sulfate EP Impurity H
- CID13342
- MSK15295
- NSC90636
- BBF-05883
- BDBM50012278
- EBC-27480
- NSC816570
- VINBLASTINE (REFERENCE GRADE)
- ZINC85432544
- AKOS015965500
- C46-H58-N4-O9
- ACN-047385
- CS-1336
- DB00570
- LS-1859
- NSC-816570
- (2xi,3beta,4'beta,19xi)-vincaleukoblastine
- NCGC00022585-04
- NCGC00022585-05
- NCGC00485975-02
- (2 beta,6 beta)-Vincaleukoblastine
- AC-24191
- AN-47800
- AS-15821
- BP-43221
- BP-44608
- HY-17418
- Q943
- VinblastineVincaleukoblastine; Vinblastina
- (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
- 1012B
- FT-0699091
- FT-0776227
- J1.596.263A
- J2.533.893F
- W-5281
- VLB
- 139299-EP2270008A1
- 139299-EP2292617A1
- 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid
- A922742
- EN300-19874057
- VINDESINE SULFATE IMPURITY B [EP IMPURITY]
- VINCRISTINE SULFATE IMPURITY H [EP IMPURITY]
- BRD-K01188359-001-02-0
- BRD-K01188359-001-03-8
- BRD-K01188359-065-02-5
- BRD-K01188359-065-23-1
- (2alpha,2'beta,3alpha,5beta,19beta)-vincaleukoblastine
- 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid, 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-, methyl ester, (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-
- methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- Vindesine Sulfate EP Impurity B; Vincristine EP Impurity H
- (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate
- (2ALPHA,2''''BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
- tert-butyl (2S)-2-[(1R,2S)-1-methoxy-2-methylbut-3-enyl]pyrr
- methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
- [3aR-[3aa,4b,5b,5ab,9(3R*,5S*,7R*,9S*),10bR*,13aa]]-Methyl 4-(acetyloxy)-3a-ethyl-9-[5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino[5,4-b]indol-9-yl]-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino[8,1-cd]carbazole-5-carboxylate
- 132142-72-4
- 143-67-9
- 212-734-0
- 363623-08-9
- methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-((13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo(13.3.1.0^(4,12).0^(5,10))nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.0^(1,9).0^(2,7).0^(16,19))nonadeca-2(7),3,5,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-((13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2(7),3,5,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-((13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2,4,6,13-tetraene-10-carboxylate